Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality

被引:0
作者
Jin, Jing [1 ]
Gummidipundi, Santosh [2 ]
Hsu, Joe [2 ]
Sharifi, Husham
Boothroyd, Derek [2 ]
Krishnan, Anandi [3 ,4 ]
Zehnder, James L. [2 ,3 ]
机构
[1] Stanford Hlth Care, Dept Special Coagulat, Clin Labs, Stanford, CA USA
[2] Stanford Univ, Sch Med, Dept Med, Stanford, CA USA
[3] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA USA
[4] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA
关键词
activated partial thromboplastin time; anti-factor Xa; concordance; discordant; unfractionated heparin; HEPARIN; AGREEMENT; COLLEGE;
D O I
10.1055/s-0044-1789020
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The activated partial thromboplastin time (aPTT) and anti-factor-Xa levels (anti-Xa) are both used to monitor patients on unfractionated heparin. Our previous study demonstrated that patients with discordant high aPTT relative to anti-Xa had higher rates of mortality and bleeding events. Objective To determine if underlying patient characteristics drive both discordance and adverse outcomes or if discordance is an independent risk factor to adverse outcomes. Methods We analyzed all patients hospitalized at the Stanford Hospital between January 2011 and December 2019 who had simultaneous aPTT and anti-Xa levels performed. From the electronic medical record, we extracted and analyzed 51 patient features including baseline coagulation laboratory results, demographics, values of other common laboratories (basic metabolic panel, complete blood count, etc.), diagnostic procedures, medications, and death. Results A total of 17,728 patients had 78,701 paired aPTT and anti-Xa levels. Patients with discordant aPTT and anti-Xa where aPTT (seconds) was elevated beyond the expected therapeutic range had a higher 30-day mortality (odds ratio [OR]: 2.16, 95% confidence interval [CI]: 1.78-2.63, p < 0.001). Sectioning the patients based on the degree of discordance and whether aPTT or anti-Xa were signaling excess anticoagulation, we found those with an elevated aPTT discordant to their anti-Xa level had the highest odds of death (OR: 2.46, 95% CI: 1.99-3.10) compared with the concordant group. This finding was still present after controlling for patient comorbidity and other laboratory results at hospital admission. Conclusion After controlling for patient features strongly associated with increased mortality in heparinized patients, we identified that the discordant pattern of high aPTT to anti-Xa served as an independent predictor of 30-day all-cause mortality, with a higher degree of discordance associated with increased odds of 30-day mortality.
引用
收藏
页数:9
相关论文
共 16 条
  • [11] Discordant aPTT and Anti-Xa Values and Outcomes in Hospitalized Patients Treated with Intravenous Unfractionated Heparin
    Price, Elizabeth A.
    Jin, Jing
    Nguyen, Huong
    Krishnan, Gomathi
    Bowen, Raffick
    Zehnder, James L.
    [J]. ANNALS OF PHARMACOTHERAPY, 2013, 47 (02) : 151 - 158
  • [12] Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin
    Ratano, Damian
    Alberio, Lorenzo
    Delodder, Frederik
    Faouzi, Mohamed
    Berger, Mette M.
    [J]. THROMBOSIS RESEARCH, 2019, 175 : 53 - 58
  • [13] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
  • [14] Two instruments to determine activated partial thromboplastin time: Implications for heparin monitoring
    Taylor, CT
    Petros, WP
    Ortel, TL
    [J]. PHARMACOTHERAPY, 1999, 19 (04): : 383 - 387
  • [15] Antifactor Xa Levels versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin
    Vandiver, Jeremy W.
    Vondracek, Thomas G.
    [J]. PHARMACOTHERAPY, 2012, 32 (06): : 546 - 558
  • [16] IgMk paraprotein from gammopathy patient can bind to cardiolipin and interfere with coagulation assay: a case report
    Wu, Xin-yao
    Yin, Yu-feng
    Teng, Jia-lin
    Zhang, Li-wei
    Yang, Cheng-de
    [J]. BMC IMMUNOLOGY, 2017, 18